[go: up one dir, main page]

DE69110135D1 - Neuroleptische perhydro-1h-pyrido(1,2-alpha)pyrazine. - Google Patents

Neuroleptische perhydro-1h-pyrido(1,2-alpha)pyrazine.

Info

Publication number
DE69110135D1
DE69110135D1 DE69110135T DE69110135T DE69110135D1 DE 69110135 D1 DE69110135 D1 DE 69110135D1 DE 69110135 T DE69110135 T DE 69110135T DE 69110135 T DE69110135 T DE 69110135T DE 69110135 D1 DE69110135 D1 DE 69110135D1
Authority
DE
Germany
Prior art keywords
alkyl
pyrido
pyrazine
alpha
perhydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69110135T
Other languages
English (en)
Other versions
DE69110135T2 (de
Inventor
Gene BRIGHT
Kishor DESAI
Thomas Seeger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Inc
Original Assignee
Pfizer Corp Belgium
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Inc filed Critical Pfizer Corp Belgium
Application granted granted Critical
Publication of DE69110135D1 publication Critical patent/DE69110135D1/de
Publication of DE69110135T2 publication Critical patent/DE69110135T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE69110135T 1991-02-27 1991-11-18 Neuroleptische perhydro-1h-pyrido(1,2-alpha)pyrazine. Expired - Fee Related DE69110135T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/661,791 US5157034A (en) 1991-02-27 1991-02-27 Neuroleptic perhydro-1H-pyrido[1,2-a]pyrazines
PCT/US1991/008378 WO1992015580A1 (en) 1991-02-27 1991-11-18 NEUROLEPTIC PERHYDRO-1H-PYRIDO[1,2-a]PYRAZINES

Publications (2)

Publication Number Publication Date
DE69110135D1 true DE69110135D1 (de) 1995-07-06
DE69110135T2 DE69110135T2 (de) 1995-10-19

Family

ID=24655130

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69110135T Expired - Fee Related DE69110135T2 (de) 1991-02-27 1991-11-18 Neuroleptische perhydro-1h-pyrido(1,2-alpha)pyrazine.
DE9190206U Expired - Lifetime DE9190206U1 (de) 1991-02-27 1991-11-18 Neuroleptische Perhydro-1H-pyrido/1,2-a/pyrazine

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE9190206U Expired - Lifetime DE9190206U1 (de) 1991-02-27 1991-11-18 Neuroleptische Perhydro-1H-pyrido/1,2-a/pyrazine

Country Status (24)

Country Link
US (1) US5157034A (de)
EP (1) EP0573467B1 (de)
JP (1) JP2546770B2 (de)
KR (1) KR0163413B1 (de)
AT (1) ATE123284T1 (de)
AU (1) AU652422B2 (de)
CA (2) CA2163274C (de)
DE (2) DE69110135T2 (de)
DK (1) DK0573467T3 (de)
ES (1) ES2073914T3 (de)
FI (3) FI105030B (de)
HU (1) HU216637B (de)
IE (1) IE67190B1 (de)
IL (2) IL112325A (de)
MX (1) MX9200803A (de)
MY (1) MY108185A (de)
NO (1) NO300847B1 (de)
NZ (1) NZ241739A (de)
PT (1) PT100160B (de)
RU (1) RU2090565C1 (de)
TW (1) TW207540B (de)
WO (1) WO1992015580A1 (de)
YU (1) YU48311B (de)
ZA (1) ZA921405B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69218414T2 (de) * 1991-02-27 1998-01-22 Pfizer Verfahren zur herstellung von trans-piperidin-2,5-dicarboxylaten
ES2137986T3 (es) * 1992-06-16 2000-01-01 Pfizer Procedimiento y productos intermedios para agentes ansioliticos bis-aza-biciclicos.
US6231833B1 (en) 1999-08-05 2001-05-15 Pfizer Inc 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors
US5731307A (en) * 1994-09-30 1998-03-24 Pfizer, Inc. Neuroleptic 2,7-disubtituted perhydro-1h-pyrido 1, 2-A!pyrazines
AU681310B2 (en) * 1994-09-30 1997-08-21 Pfizer Inc. 2,7-substituted octahydro-1h-pyrido{1,2-a}pyrazine derivatives
PA8469101A1 (es) * 1998-04-09 2000-09-29 Pfizer Prod Inc Ligandos azabiciclicos de receptores 5ht1
UA62015C2 (en) * 1998-12-28 2003-12-15 Pfizer Prod Inc Benzoizoxazol derivatives, a pharmaceutical composition (variants) based thereon (variants) and a method for treatment (variants)
WO2004081007A1 (en) * 2003-03-12 2004-09-23 Pfizer Products Inc. Pyridyloxymethyl and benzisoxazole azabicyclic derivatives
ES2563304T3 (es) * 2003-04-24 2016-03-14 Incyte Holdings Corporation Derivados azaespiro alcano como inhibidores de metaloproteasas
WO2007143600A2 (en) * 2006-06-05 2007-12-13 Incyte Corporation Sheddase inhibitors combined with cd30-binding immunotherapeutics for the treatment of cd30 positive diseases
WO2014078568A1 (en) 2012-11-14 2014-05-22 The Johns Hopkins University Methods and compositions for treating schizophrenia

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4681938A (en) * 1984-08-27 1987-07-21 Ciba-Geigy Corporation Novel polycyclic hydrazones of rifamycins, their manufacture, and their pharmaceutical compositions for treating tuberculosis
US4831031A (en) * 1988-01-22 1989-05-16 Pfizer Inc. Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity
US4957916A (en) * 1988-08-05 1990-09-18 Janssen Pharmaceutica N.V. Antipsychotic 3-piperazinylbenzazole derivatives
WO1990008148A1 (en) * 1989-01-23 1990-07-26 Pfizer Inc. Bis-aza-bicyclic anxiolytic agents

Also Published As

Publication number Publication date
EP0573467B1 (de) 1995-05-31
YU48311B (sh) 1998-05-15
RU2090565C1 (ru) 1997-09-20
DE69110135T2 (de) 1995-10-19
CA2163274C (en) 1999-02-09
NO300847B1 (no) 1997-08-04
EP0573467A1 (de) 1993-12-15
FI114214B (fi) 2004-09-15
KR930703315A (ko) 1993-11-29
AU652422B2 (en) 1994-08-25
IE920601A1 (en) 1992-09-09
ATE123284T1 (de) 1995-06-15
HU9302427D0 (en) 1993-11-29
NO933049D0 (no) 1993-08-26
NO933049L (no) 1993-08-26
TW207540B (de) 1993-06-11
HU216637B (hu) 1999-07-28
CA2101518C (en) 1997-11-25
IE67190B1 (en) 1996-03-06
PT100160B (pt) 1999-09-30
MY108185A (en) 1996-08-30
FI20030361L (fi) 2003-03-11
DK0573467T3 (da) 1995-10-09
ES2073914T3 (es) 1995-08-16
US5157034A (en) 1992-10-20
IL112325A (en) 1997-08-14
YU19892A (sh) 1994-11-15
ZA921405B (en) 1993-08-26
DE9190206U1 (de) 1993-10-14
AU1259992A (en) 1992-10-06
IL112325A0 (en) 1995-03-30
MX9200803A (es) 1992-08-31
HUT66965A (en) 1995-01-30
FI933753L (fi) 1993-08-26
NZ241739A (en) 1994-07-26
PT100160A (pt) 1993-05-31
JP2546770B2 (ja) 1996-10-23
FI112865B (fi) 2004-01-30
JPH06500120A (ja) 1994-01-06
CA2163274A1 (en) 1992-08-28
KR0163413B1 (ko) 1998-12-01
IL101021A (en) 1996-03-31
FI933753A0 (fi) 1993-08-26
FI20000354L (fi) 2000-02-17
FI105030B (fi) 2000-05-31
WO1992015580A1 (en) 1992-09-17
CA2101518A1 (en) 1992-08-28

Similar Documents

Publication Publication Date Title
ATE123284T1 (de) Neuroleptische perhydro-1h-pyrido(1,2- alpha)pyrazine.
DK0478954T3 (da) Serotonin 5HT1A- og 5HT1D-antagonister
SE8502432D0 (sv) Improvement of flow properties of injection moldable aromatic polyesters
ATE130850T1 (de) Fulgimidderivate.
ATE268803T1 (de) Magenta-tintengemisch und aufzeichnungsverfahren damit
YU101791A (sh) Supstituisani ftalidi i heterociklični ftalidi
ES2116555T3 (es) Nuevos derivados naftalenicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
DE69217877D1 (de) Feste kosmetische Zusammensetzung auf Öl-Basis
FI894352A0 (fi) Optiskt icke-lineaera aktiva organiska foereningar och elektrooptiska apparater innehaollande dessa.
MX9203360A (es) Derivados de hexahidroazepinas y composiciones farmaceuticas que los contienen.
DE69209787D1 (de) Herstellung von Pigmentzusammensetzungen
DE69201520D1 (de) Piperidinderivate, ihre Herstellung und Verwendung.
DE69115867D1 (de) Synthese von 2-Aryl-5-(trifluormethyl)pyrrolen als pestizide Wirkstoffe und als Zwischenprodukte bei der Herstellung dieser Wirkstoffe
DE69416191D1 (de) Spiropyran-Derivate mit photochromischen Eigenschaften
ITRM920062A0 (it) Composizione di inchiostro indelebile di tipo etanolico.
ES2052807T3 (es) Tienil-piperazinonas, su obtencion y empleo.
DK0623620T3 (da) 5-HT3-pyrrolopyrazinderivater
GR77375B (de)
DE69007537D1 (de) Tintenzusammensetzungen auf wässeriger Basis.
IT1263892B (it) Composti piperidin-triazinici atti all'impiego come stabilizzanti per materiali organici
DK0445013T3 (da) N-Cycloalkylalkylaminer, fremgangsmåde til fremstilling deraf, deres anvendelse som lægemiddel og deres syntese-mellemprodukter
FI810618L (fi) Nya kefalosporiner foerfarande foer deras framstaellning och dessa foereningar innehaollande laekemedel
ATE127806T1 (de) Antibiotikverbindungen und ihre herstellung.
ATE462689T1 (de) Vitamin-d-derivate mit substituenten an der 2- alpha-position
ATE151736T1 (de) 2-arylpropensäuren und ihre verwendung bei der herstellung von s-ketoprofen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee